Jean-Claude Vedovato
Jean-Claude Vedovato publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Cancer Treatment and Pharmacology.
- World rank
- #4,242,028 of 7,710,434 ranked researchers
- Rank in France
- #178,502 of 324,115
- Works
- 16
- Citations
- 447
- Citations per work
- 27.9
What does Jean-Claude Vedovato research?
Jean-Claude Vedovato's work is mostly in Medicine (81%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1380.8%
- Medicine1380.8%
- Life Sciences214.8%
- Everything else14.4%
- 1Oncology47% of their works
- 2Pulmonary and Respiratory Medicine32% of their works
- 3Molecular Biology11% of their works
- 4Cancer Research2% of their works
- 5Immunology2% of their works
- 6Hematology2% of their works
Research topics
Which keywords describe Jean-Claude Vedovato's research?
The keywords of their largest research topics: Chemotherapy, Molecular Subtypes, Cetuximab, KRAS Mutations, EGFR Mutations, Targeted Therapy, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- Gene Expression
- Topoisomerases
- DNA
- MAP Kinase
- Endoscopic Resection
- Survival Analysis
- Taxanes
- Targeted Therapy
- KRAS Mutations
- Molecular Subtypes
- Chemotherapy
- Cetuximab
- EGFR Mutations
- Chemotherapy-Induced Peripheral Neuropathy
- Clinical Practice Guidelines
- BRAF gene
- Gastric Cancer
- Breast Cancer
- HER2
- Breast Tumours
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy194 topics
- Molecular Subtypes132 topics
- Cetuximab121 topic
- KRAS Mutations121 topic
- EGFR Mutations111 topic
- Targeted Therapy111 topic
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Taxanes61 topic
- Clinical Practice Guidelines42 topics
- Survival Analysis42 topics
- BRAF gene31 topic
- Endoscopic Resection31 topic
- Gastric Cancer31 topic
- MAP Kinase31 topic
- Breast Cancer21 topic
- DNA21 topic
- HER221 topic
- Topoisomerases21 topic
- Breast Tumours11 topic
- Gene Expression11 topic
Where does Jean-Claude Vedovato work?
Jean-Claude Vedovato's main affiliation in the publication record is Pierre Fabre (France), France.
How many publications and citations does Jean-Claude Vedovato have?
OpenAlex counts 16 works and 447 citations for Jean-Claude Vedovato, an h-index of 11, ranking #4,242,028 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jean-Claude Vedovato. Posts are plain text and can be reported.